BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 574032)

  • 1. AET-treated platelets: their usefulness for platelet antibody detection and an examination of their altered sensitivity to immune lysis.
    Cimo PL; Gerber SA
    Blood; 1979 Nov; 54(5):1101-8. PubMed ID: 574032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.
    Aster RH; Enright SE
    J Clin Invest; 1969 Jul; 48(7):1199-210. PubMed ID: 5798625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome.
    van Leeuwen EF; Engelfriet CP; von dem Borne AE
    Br J Haematol; 1982 Aug; 51(4):551-60. PubMed ID: 7049220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement.
    Ezzell JL; Wilcox LA; Bernshaw NJ; Parker CJ
    Blood; 1991 Jun; 77(12):2764-73. PubMed ID: 1710519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of complement proteins on membranes of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Burapakulsolsri N; Yuthavong Y; Wilairat P
    Br J Haematol; 1979 Mar; 41(3):393-8. PubMed ID: 427043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased susceptibility of tumor cells and chicken erythrocytes to lysis by antibody and complement after treatment with aminoethylisothiouronium bromide hydrobromide (AET).
    Langone JJ; Borsos T
    J Immunopharmacol; 1978-1979; 1(1):43-59. PubMed ID: 401313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura.
    Tsubakio T; Tani P; Curd JG; McMillan R
    Br J Haematol; 1986 Jun; 63(2):293-300. PubMed ID: 3718872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole.
    Cimo PL; Pisciotta AV; Desai RG; Pino JL; Aster RH
    Am J Hematol; 1977; 2(1):65-72. PubMed ID: 868869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-loaded erythrocytes have a defect in complement regulation distinct from that resulting from exposure to 2-aminoethylisothiouronium bromide.
    Test ST; Mitsuyoshi J
    Blood; 1995 Oct; 86(7):2799-806. PubMed ID: 7545473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH; Rosse WF
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune lysis of AET-treated normal red cells (PNH-like cells).
    Sirchia G; Dacie JV
    Nature; 1967 Aug; 215(5102):747-8. PubMed ID: 6059545
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet antibody in idiopathic thrombocytopenic purpura and other thrombocytopenias. A quantitative, sensitive, and rapid assay.
    Sugiura K; Steiner M; Baldini MG
    J Lab Clin Med; 1980 Oct; 96(4):640-53. PubMed ID: 6968331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide.
    Advani H; Zamor J; Judd WJ; Johnson CL; Marsh WL
    Br J Haematol; 1982 May; 51(1):107-15. PubMed ID: 7073987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscope study of PNH red cells and AET-treated normal red cells (PNH-like cells).
    Lewis SM; Lambertenghi G; Ferrone S; Sirchia G
    J Clin Pathol; 1971 Nov; 24(8):677-84. PubMed ID: 5130532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E
    Dan Med Bull; 1992 Aug; 39(4):343-54. PubMed ID: 1382006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells).
    Ferrone S; Zanella A; Sirchia G
    Acta Vitaminol Enzymol; 1970; 24(6):222-5. PubMed ID: 5537936
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttransfusion purpura associated with an autoantibody directed against a previously undefined platelet antigen.
    Stricker RB; Lewis BH; Corash L; Shuman MA
    Blood; 1987 May; 69(5):1458-63. PubMed ID: 3567361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro lysis of AET-treated normal red cells (PNH-like cells) by normal and cirrhotic sera.
    Sirchia G; Ferrone S; Mercuriali F
    Br J Haematol; 1969 Sep; 17(3):245-9. PubMed ID: 4979897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.